Walgreens Takes a Leap of Faith Into Europe

Last week we brought you a list of American companies, specifically in the retail sector, who had little to no exposure to European markets. Because of this lack of exposure, these firms could be safe havens for investors who were anxious about the tenuous situation surrounding Greece, Spain, and other member of the European Union. Perhaps we spoke too soon. One of those retailers announced Tuesday that it was making a major leap into the European economy and hoping consumers across the pond build the confidence to start spending.

Walgreen (NYSE: WAG  )  announced it would be purchasing a forty-five percent share of Alliance Boots GmbH. This transaction will create the world largest provider of prescription drugs and will mark the first time that the American drug-store giant takes their business to Europe. The retail chain has already endured a number of difficulties this year with pharmaceutical partners, and it hopes this acquisition will prove beneficial by incorporating some of the more high-end products Alliance Boots offers, allowing the company to pool resources, and lowering operating costs. 

This is a curious time for Walgreens to pull the trigger on entering the European market, although reports say the deal was in the works for more than a year. Presidential elections took place in Greece this past Sunday, and following the victory of the pro-bailout New Democracy party, many market watchers hoped this would lead to a rebound in European markets. This hope has not come to fruition as European markets reacted timidly to the news. Falling in line with the overall market, shares of Walgreens have not received a bounce off the announcement but rather fell nearly six percent as of Tuesday afternoon.

Now what?
How will the market react to this transaction? While in the short-term Walgreen's share price has taken a hit, in the long term they expect that the economies of sale they will gain as the world's largest purchaser of prescription drugs will prove beneficial for the company.

However, all of these plans could be undone if the fiscal situation in the European Union remains unresolved.

Click here to access free, interactive tools to analyze these ideas.

Interactive Chart: Press Play to compare changes in analyst ratings over the last two years for the stocks mentioned above. Analyst ratings sourced from Zacks Investment Research.


Disclosure: Kapitall's Dan Connelly does not own any of the shares mentioned above.

The Motley Fool owns shares of Ford Motor. Motley Fool newsletter services have recommended buying shares of Pfizer and Ford Motor. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.


Read/Post Comments (1) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On June 20, 2012, at 2:01 PM, 4Mike4 wrote:

    With ESI/Medco acting like the proverbial pack of wolves surrounding an apparently isolated animal, maybe WAG thinks that it can obtain bargaining power through this purchase.

    However, Europe having it's own weaknesses may have added to to WAGs problems.

    Maybe WAG should have joined with another pharmacy chain and formed it's own wolf pack against the PBMS. The enemy of my enemy is my friend.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1918897, ~/Articles/ArticleHandler.aspx, 8/27/2014 1:26:36 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Apple's next smart device (warning, it may shock you

Apple recently recruited a secret-development "dream team" to guarantee its newest smart device was kept hidden from the public for as long as possible. But the secret is out. In fact, ABI Research predicts 485 million of this type of device will be sold per year. But one small company makes Apple's gadget possible. And its stock price has nearly unlimited room to run for early-in-the-know investors. To be one of them, and see Apple's newest smart gizmo, just click here!


Advertisement